# Caris Life Sciences Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance

- Source: PR Newswire M&A
- Published: 2026-11-04T21:05:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/caris-life-sciences-reports-third-quarter-2026-financial-results-and-increases-2026-revenue-guidance-302929429.html
- Canonical: https://groundlevelnews.com/story/caris-life-sciences-reports-third-quarter-2026-financial-results-and-i-a3ead2/

Revenue growth of 27% driven by strong performance in molecular profiling services, including approximately 61,500 clinical cases, consisting of over 358,000 total oncology tests Raises 2026 revenue guidance to $1.04 to $1.05 billion, representing growth of 28% to 29% IRVING, Texas, Nov....

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._